SecBot SecBot
8-K ·Filed Sep 15, 2026

VNRX

VOLITIONRX LTD
BEARISH
Impact 5/10
Horizondays Processed1mo ago SEC0001477932-26-005620
8-K context-dependent: Items 3.02
Actionable Insight ▼ Bearish

The unregistered equity sale signals potential dilution, but the lack of disclosed terms limits the read-through. Monitor for a follow-up 8-K or prospectus supplement detailing share count, price, and use of proceeds to gauge the dilution percentage and discount to market.

DirectionBearish
Confidencelow
Horizondays
Latest settled — T+20d
VNRX ▼ -34.89% at T+20d
SHORT call ✓ call won +34.89% · α vs SPY +36.95% · entry $0.2749 → $0.1790
Next anchor: T+60d in 6w
Latest observation: T+27 -27.13% FF3 residual α
Entry = T+0 close
Sep 15, 2026
via day close
T+1d
+3.64%
call -3.64% · α -2.50%
$0.2849
settled 6w ago
T+5d
-10.15%
call +10.15% · α +12.71%
$0.2470
settled 5w ago
T+20d
-34.89%
call +34.89% · α +36.95%
$0.1790
settled 14d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

VolitionRx Limited (VNRX) filed an 8-K under Item 3.02 to disclose an unregistered sale of equity securities, indicating a dilutive capital raise. The filing provides no financial details on share count, price, or use of proceeds, making the magnitude of dilution and its impact on existing shareholders unclear.

Key Facts

  • Filing discloses unregistered sales of equity securities under Item 3.02.
  • No share count, price, or dollar amount was disclosed in the filing.
  • No use of proceeds was specified in the filing.

Financial Impact

Undisclosed amount — no share count, price, or proceeds disclosed in the filing.

dilutionshare count

Risk Factors

  • Undisclosed offering size could result in meaningful dilution to existing shareholders.
  • Shares sold at a discount to market could pressure the stock price.
  • Lack of detail creates uncertainty around the company's cash runway and capital needs.

Market Snapshot

Exchange
NYSE
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001477932-26-005620
Document: 0001477932-26-005620-index-headers.html0001477932-26-005620
Document: 0001477932-26-005620-index.html0001477932-26-005620
Document: 0001477932-26-005620.txt0001477932-26-005620
19 reports for VNRX
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 11 of 12 best @ T+60▲ +83.65%Jul 20, 2026
Filters
Rows
Reports for VNRX — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
8-K
BEARISH ★ 7/10
$0.2529awaiting T+60—$0.1800 (+28.83%)
Sep 16, 2026
5w ago
SC 13D/A
NEUTRAL ★ 3/10
$0.2849awaiting T+60—$0.1800 (−36.82%)
Sep 15, 2026
5w ago
8-K
BEARISH ★ 5/10
$0.2749awaiting T+60—$0.1800 (+34.52%)
Sep 11, 2026
6w ago
EFFECT
BEARISH ★ 7/10
$0.3102awaiting T+60—$0.1800 (+41.97%)
Sep 8, 2026
6w ago
S-3/A
BEARISH ★ 7/10
$0.3400awaiting T+60—$0.1800 (+47.06%)
Sep 1, 2026
7w ago
8-K
BEARISH ★ 6/10
$0.3800awaiting T+60—$0.1800 (+52.63%)
Aug 24, 2026
9w ago
8-K
BEARISH ★ 6/10
$0.3846awaiting T+60—$0.1800 (+53.20%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 6/10
$0.7700awaiting T+60—$0.1800 (+76.62%)
Jul 20, 2026
14w ago
EFFECT
BEARISH ★ 6/10
$1.13 $0.1847▲ +83.65%▲ +88.50%$0.1800 (+84.07%)
Jun 18, 2026
18w ago
8-K
BEARISH ★ 6/10
$1.34awaiting T+60—$0.1800 (+86.57%)
Showing 10 of 19

US Market Status

Market Closed — Opens Wed (10h 11m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026